Relapsed/Refractory Hematological Malignancies

Explore clinical trials studying Relapsed/Refractory Hematological Malignancies. Study availability and eligibility vary by location and protocol.

2 public trials 1 recruiting study

Refine in advanced search Browse all conditions

Relapsed/Refractory Hematological Malignancies trial results

Recruiting

NCT07424833

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +33 more
Locations: Mayo Clinic Jacksonville, Florida, United States

Henan Cancer Hospital Zhengzhou, Henan, China

START Los Angele Los Angeles, California, United States

START Midwest Grand Rapids, Michigan, United States

Not Yet Recruiting

NCT07294300

Conditions: Hematologic Diseases, Hematologic Neoplasms, Hemic and Lymphatic Diseases, +3 more
Locations: Shanghai Jiaotong University School of Medicine Ruijin Hospital Shanghai, Shanghai Municipality, China